Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RVTY

Revvity Inc

Oct 24 • 04:00PM ET

98.89

+1.32 1.35 %

Healthcare • Diagnostics & Research • USA • NYSE

Peers: TMO DHR A MTD BIO WAT BRKR ILMN

| Held by: VTI VOO VB RSP VBR IVV SPY TCAF XLV IWR

Scroll to Statements

Index	S&P 500	P/E	41.96	EPS (ttm)	2.36	Insider Own	0.41%	Shs Outstand	116.33M	Perf Week	5.86%
Market Cap	11.48B	Forward P/E	18.72	EPS next Y	5.28	Insider Trans	-0.23%	Shs Float	115.59M	Perf Month	19.09%
Enterprise Value	13.86B	PEG	6.80	EPS next Q	1.14	Inst Own	100.59%	Short Float	6.98%	Perf Quarter	4.05%
Income	285.49M	P/S	4.10	EPS this Y	-0.85%	Inst Trans	-0.30%	Short Ratio	6.15	Perf Half Y	4.88%
Sales	2.80B	P/B	1.52	EPS next Y	8.76%	ROA	2.16%	Short Interest	8.07M	Perf YTD	-11.40%
Book/sh	64.95	P/C	11.56	EPS next 5Y	6.17%	ROE	3.61%	52W High	129.50 -23.64%	Perf Year	-16.75%
Cash/sh	8.55	P/FCF	22.93	EPS past 3/5Y	-33.21% 3.37%	ROIC	2.61%	52W Low	81.36 21.55%	Perf 3Y	-22.54%
Dividend Est.	0.27 (0.27%)	EV/EBITDA	16.49	Sales past 3/5Y	-10.38% -0.91%	Gross Margin	50.58%	Volatility	2.79% 3.04%	Perf 5Y	-19.14%
Dividend TTM	0.28 (0.28%)	EV/Sales	4.95	EPS Y/Y TTM	32.86%	Oper. Margin	15.28%	ATR (14)	2.84	Perf 10Y	103.52%
Dividend Ex-Date	Jan 16, 2026	Quick Ratio	2.75	Sales Y/Y TTM	3.33%	Profit Margin	10.20%	RSI (14)	67.23	Recom	2.10
Dividend Gr. 3/5Y	0.00% 0.00%	Current Ratio	3.33	EPS Q/Q	-26.91%	SMA20	6.83%	Beta	1.00	Target Price	110.27
Payout	11.63%	Debt/Eq	0.45	Sales Q/Q	4.13%	SMA50	10.65%	Rel Volume	1.60	Prev Close	97.57
Employees	11000	LT Debt/Eq	0.45	Earnings	Oct 27 BMO	SMA200	-0.09%	Avg Volume	1.31M	Price	98.89
IPO	Jul 06, 1965	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.78% 1.34%	Trades		Volume	2,102,032	Change	1.35%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-16-25	Initiated	Guggenheim	Neutral
May-01-25	Upgrade	UBS	Neutral → Buy	$115
Jan-10-25	Downgrade	Bernstein	Outperform → Mkt Perform	$130
Dec-13-24	Upgrade	BofA Securities	Neutral → Buy	$138
Oct-15-24	Upgrade	Barclays	Equal Weight → Overweight	$125 → $140
Aug-28-24	Initiated	Wells Fargo	Equal Weight	$130
Jul-08-24	Initiated	Leerink Partners	Outperform	$125
Jun-03-24	Resumed	Jefferies	Hold	$115
Jan-16-24	Downgrade	UBS	Buy → Neutral	$105 → $125
Jan-04-24	Upgrade	Evercore ISI	In-line → Outperform	$88 → $125
Dec-19-23	Initiated	Wells Fargo	Equal Weight	$95
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Sep-28-23	Initiated	Bernstein	Outperform	$133
Jul-19-23	Initiated	Raymond James	Outperform	$145
May-23-23	Resumed	Goldman	Buy	$150

Show Previous Ratings

Today 11:02PM	Revvity (RVTY) Q3 Earnings Report Preview: What To Look For (StockStory)
Oct-23-25 04:05PM	Revvity Board Declares Quarterly Dividend (Business Wire)
07:53AM	Will RVTY Q3 Earnings Reflect Segmental Strength Amid Rising Demand? (Zacks)
Oct-22-25 09:15AM	Revvity (RVTY) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Oct-21-25 10:00AM	Labcorp Holdings (LH) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
10:00AM	Loading…
Oct-20-25 10:00AM	Analysts Estimate Revvity (RVTY) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-16-25 02:40AM	Here's What to Expect From Revvity's Next Earnings Report (Barchart)
Oct-14-25 11:35PM	Research Tools & Consumables Stocks Q2 Teardown: Revvity (NYSE:RVTY) Vs The Rest (StockStory)
08:00AM	Revvity Showcases Progress with Purpose in 2025 Impact Report (Business Wire)
Oct-13-25 11:38AM	Analyst Report: Revvity, Inc. (Morningstar Research)
Oct-09-25 11:55AM	RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes (Zacks)
Oct-06-25 08:00AM	Revvity to Hold Earnings Call on Monday, October 27, 2025 (Business Wire)
Oct-02-25 08:00AM	Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes (Business Wire)
Sep-29-25 08:00AM	Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis (Business Wire)
Sep-23-25 02:26PM	Revvity Stock: Is RVTY Underperforming the Healthcare Sector? (Barchart)
08:00AM	Loading…
Sep-22-25 08:00AM	Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems (Business Wire)
Sep-12-25 12:35AM	1 Oversold Stock Primed to Rebound and 2 We Brush Off (StockStory)
Sep-10-25 04:53AM	Revvity, Inc. (RVTY) Launches its New In Vivo Imaging Center of Excellence (Insider Monkey)
Sep-03-25 12:36PM	Revvity (RVTY) Stock Trades Down, Here Is Why (StockStory) -5.13%
Sep-02-25 02:26PM	Why Revvity (RVTY) Stock Is Trading Lower Today (StockStory)
08:00AM	Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina (Business Wire)
Aug-27-25 04:32PM	Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-Annual Reconstitution (PR Newswire)
Aug-18-25 08:00AM	Revvity to Present at Upcoming Investor Conferences (Business Wire)
12:02AM	3 Reasons to Sell RVTY and 1 Stock to Buy Instead (StockStory)
Aug-13-25 12:23AM	The Top 5 Analyst Questions From Revvity's Q2 Earnings Call (StockStory)
12:21AM	RVTY Q2 Deep Dive: China Diagnostics Headwinds Offset Life Sciences Stability (StockStory)
Aug-12-25 02:20PM	Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know (StockStory)
Aug-06-25 08:00AM	Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics (Business Wire)
Jul-30-25 09:25AM	Revvity price target lowered to $110 from $120 at Stifel (TipRanks)
Jul-29-25 03:02AM	Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ... (GuruFocus.com)
02:15PM	Loading…
Jul-28-25 02:15PM	Why Revvity (RVTY) Stock Is Falling Today (StockStory) -8.32%
11:51AM	Revvity Slashes Outlook As China Policy Deals Diagnostics Blow (Benzinga)
11:51AM	Analyst Report: Revvity, Inc. (Morningstar Research)
10:11AM	RVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View (Zacks)
09:30AM	Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:39AM	Revvity Stock Tumbles After Earnings. What's Dragging on the Shares. (Barrons.com)
07:10AM	Revvity (RVTY) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
06:26AM	Revvity (NYSE:RVTY) Surprises With Q2 Sales (StockStory)
06:07AM	Revvity: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Revvity Announces Financial Results for the Second Quarter of 2025 (Business Wire)
Jul-26-25 11:04PM	What To Expect From Revvity's (RVTY) Q2 Earnings (StockStory)
Jul-25-25 12:10PM	Why Revvity (RVTY) is Poised to Beat Earnings Estimates Again (Zacks)
Jul-24-25 04:05PM	Revvity Board Declares Quarterly Dividend (Business Wire)
11:11AM	Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat? (Zacks)
Jul-23-25 09:15AM	Wall Street's Insights Into Key Metrics Ahead of Revvity (RVTY) Q2 Earnings (Zacks)
Jul-22-25 10:00AM	GeneDx Holdings Corp. (WGS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks) +5.96%
Jul-21-25 10:00AM	Revvity (RVTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-15-25 09:22AM	Earnings Preview: What to Expect From Revvity's Report (Barchart)
Jul-13-25 11:31PM	Reflecting On Research Tools & Consumables Stocks' Q1 Earnings: Revvity (NYSE:RVTY) (StockStory)
Jul-11-25 12:03AM	3 Reasons to Sell RVTY and 1 Stock to Buy Instead (StockStory)
Jul-07-25 08:00AM	Revvity to Hold Earnings Call on Monday, July 28, 2025 (Business Wire)
Jul-03-25 12:37AM	3 Low-Volatility Stocks in the Doghouse (StockStory)
Jun-30-25 07:20AM	5 Insightful Analyst Questions From Revvity's Q1 Earnings Call (StockStory)
Jun-27-25 10:25AM	Revvity price target lowered to $110 from $116 at BofA (TipRanks)
Jun-24-25 11:13AM	Is Revvity Stock Underperforming the Dow? (Barchart)
Jun-05-25 11:31AM	Pediatrix Medical Group (MD) Down 3.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-02-25 08:00AM	Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows (Business Wire)
May-23-25 10:47AM	RVTY Stock Falls Despite the Latest Launch of Automated Instrument (Zacks)
May-19-25 05:00PM	AstroNova Sends Letter to Shareholders Highlighting Growth Strategy and Strength of Board (Business Wire)
08:00AM	Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing (Business Wire)
May-14-25 04:54PM	S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal (Investopedia) -5.88%
May-06-25 12:35AM	3 S&P 500 Stocks in the Doghouse (StockStory)
May-01-25 12:40AM	1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid (StockStory)
Apr-30-25 08:00AM	Revvity to Present at Upcoming Investor Conferences (Business Wire)
Apr-29-25 05:57AM	Company News for Apr 29, 2025 (Zacks)
03:02AM	Revvity Inc (RVTY) Q1 2025 Earnings Call Highlights: Surpassing Expectations with Strong ... (GuruFocus.com)
01:20AM	Q1 2025 Revvity Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-28-25 01:18PM	RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up (Zacks)
11:49AM	Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript (Seeking Alpha)
11:13AM	Analyst Report: Revvity, Inc. (Morningstar Research)
10:47AM	Biotech Firm Revvity Reports Better-Than-Expected Earnings (Investopedia)
09:30AM	Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:32AM	Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook (Reuters)
07:15AM	Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates (Zacks)
06:09AM	Revvity: Q1 Earnings Snapshot (Associated Press Finance)
06:06AM	Revvity (NYSE:RVTY) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
06:00AM	Revvity Announces Financial Results for the First Quarter of 2025 (Business Wire)
Apr-27-25 03:01AM	Revvity (RVTY) Q1 Earnings Report Preview: What To Look For (StockStory)
Apr-25-25 12:10PM	Why Revvity (RVTY) Could Beat Earnings Estimates Again (Zacks)
08:00AM	Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely? (Zacks)
Apr-24-25 04:05PM	Revvity Board Declares Quarterly Dividend (Business Wire)
07:45AM	Bretton Fund Q1 2025 Shareholder Letter (Seeking Alpha)
Apr-23-25 10:01AM	Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-21-25 10:00AM	Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline (Zacks)
Apr-10-25 01:31PM	Analyst Report: Revvity, Inc. (Morningstar Research) -8.21%
Apr-03-25 08:00AM	Revvity to Hold Earnings Call on Monday, April 28, 2025 (Business Wire) -5.59%
05:21AM	FDA approves Revvitys Auto-Pure platform and tuberculosis test combo (Medical Device Network)
Apr-02-25 08:00AM	Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test (Business Wire)
07:47AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
Mar-21-25 12:53PM	Revvity Stock Tumbles Despite Expanding Genomics England Alliance (Zacks)
Mar-20-25 08:13PM	Analyst Report: Revvity, Inc. (Morningstar Research)
01:00PM	Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England (Business Wire)
Mar-03-25 08:00AM	Revvitys EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay (Business Wire)
04:03AM	Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks (StockStory)
Feb-28-25 04:08AM	3 Reasons to Sell RVTY and 1 Stock to Buy Instead (StockStory)
Feb-26-25 08:32AM	Do Options Traders Know Something About Revvity (RVTY) Stock We Don't? (Zacks)
Feb-20-25 12:30PM	Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group (Business Wire)
08:00AM	Revvity to Present at Upcoming Investor Conferences (Business Wire)
Feb-18-25 10:18AM	Bretton Fund: Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years (Insider Monkey)
Feb-01-25 02:03AM	Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... (GuruFocus.com)

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MICHAS ALEXIS P	Director	Aug 27 '25	Sale	89.01	500	44,505	7,270	Aug 28 04:05 PM
MICHAS ALEXIS P	Officer	Aug 27 '25	Proposed Sale	88.00	500	44,000		Aug 27 03:29 PM
McMurry-Heath Michelle	Director	May 29 '25	Sale	92.17	600	55,299	4,833	May 30 04:06 PM
McMurry-Heath Michelle	Director	May 29 '25	Proposed Sale	92.17	600	55,299		May 29 02:23 PM
McMurry-Heath Michelle	Director	Feb 06 '25	Sale	119.49	1,970	235,395	3,021	Feb 07 04:05 PM
McMurry-Heath Michelle	Director	Feb 06 '25	Proposed Sale	119.49	1,970	235,395		Feb 06 03:27 PM
Goldberg Joel S	Please See Remarks	Jan 30 '25	Option Exercise	81.29	15,170	1,233,169	48,570	Jan 31 04:05 PM
Goldberg Joel S	Please See Remarks	Jan 30 '25	Sale	126.73	15,170	1,922,513	33,400	Jan 31 04:05 PM
Goldberg Joel S	Officer	Jan 30 '25	Proposed Sale	126.73	15,170	1,922,555		Jan 30 04:05 PM
Vohra Tajinder S	Please See Remarks	Jan 07 '25	Option Exercise	81.29	5,492	446,445	25,144	Jan 08 04:05 PM
Vohra Tajinder S	Please See Remarks	Jan 07 '25	Sale	116.81	5,492	641,543	19,652	Jan 08 04:05 PM
Vohra Tajinder S	Officer	Jan 07 '25	Proposed Sale	116.81	5,492	641,539		Jan 07 04:58 PM
Singh Prahlad R.	Please See Remarks	Dec 02 '24	Option Exercise	81.29	18,365	1,492,891	108,560	Dec 03 04:05 PM
Singh Prahlad R.	Please See Remarks	Dec 02 '24	Sale	116.22	18,365	2,134,366	90,195	Dec 03 04:05 PM
Singh Prahlad R.	Officer	Dec 02 '24	Proposed Sale	115.79	18,365	2,126,483		Dec 02 10:55 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RVTY

Revvity Inc

Upgrade your FINVIZ experience